Medicus Pharma (MDCX) Share-based Compensation (2024 - 2025)

Medicus Pharma's (MDCX) quarterly Share-based Compensation came in at -$229725.0 in Q3 2025, down 200.0% on a QoQ basis from $229725.0 in Q2 2025.

Medicus Pharma (MDCX) Share-based Compensation (2024 - 2025) Analysis & Trends

Medicus Pharma (MDCX) has 2 years of Share-based Compensation data on file, last reported at -$229725.0 in Q3 2025.

Quarterly Share-based Compensation changed N/A year-over-year to -$229725.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$264590.0 (changed N/A YoY) and the FY2024 annual result came in at $356805.0, up 261.93% from the prior year.
Share-based Compensation declined to -$229725.0 in Q3 2025, from $229725.0 in the prior quarter.
In the past five years, Share-based Compensation ranged from a high of $585442.0 in Q2 2024 to a low of -$264590.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Stock Comp. (Qtr)
1	Johnson & Johnson	652.20 Bn	631.44 Bn	17.26 Bn	458.00 Mn
2	AbbVie	469.51 Bn	462.94 Bn	12.70 Bn	166.00 Mn
3	Merck	376.81 Bn	369.67 Bn	12.21 Bn	298.00 Mn
4	Novartis Ag	303.04 Bn	295.35 Bn	11.24 Bn	-
5	Astrazeneca	257.61 Bn	252.71 Bn	12.86 Bn	-
6	Amgen	237.37 Bn	223.38 Bn	7.24 Bn	165.00 Mn
7	Gilead Sciences	181.73 Bn	178.55 Bn	6.22 Bn	231.00 Mn
8	Pfizer	159.66 Bn	147.96 Bn	10.94 Bn	249.00 Mn
9	Gsk	106.24 Bn	102.07 Bn	8.24 Bn	-
10	Medicus Pharma	14.88 Mn	-298,205.43	-	-

Download Data